These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 3721943

  • 1. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.
    Saletu B, Grünberger J, Linzmayer L, Schwartz JJ, Haegele KD, Schechter PJ.
    Int J Psychophysiol; 1986 May; 4(1):63-80. PubMed ID: 3721943
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
    Saletu B, Grünberger J, Linzmayer L.
    Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364.
    Saletu B, Grünberger J, Cepko H.
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):421-37. PubMed ID: 2888736
    [Abstract] [Full Text] [Related]

  • 5. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B, Grünberger J, Linzmayer L.
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [Abstract] [Full Text] [Related]

  • 6. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM, Armijo JA.
    Biochem Pharmacol; 1992 May 28; 43(10):2143-50. PubMed ID: 1599502
    [Abstract] [Full Text] [Related]

  • 7. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats.
    Valdizán EM, Armijo JA.
    Epilepsia; 1991 May 28; 32(5):735-42. PubMed ID: 1915185
    [Abstract] [Full Text] [Related]

  • 8. Acute and subacute CNS effects of milacemide in elderly people: double-blind, placebo-controlled quantitative EEG and psychometric investigations.
    Saletu B, Grünberger J, Linzmayer L.
    Arch Gerontol Geriatr; 1986 Oct 28; 5(3):165-81. PubMed ID: 3541816
    [Abstract] [Full Text] [Related]

  • 9. Gamma-vinyl GABA: comparison of neurochemical and anticonvulsant effects in mice.
    Bernasconi R, Klein M, Martin P, Christen P, Hafner T, Portet C, Schmutz M.
    J Neural Transm; 1988 Oct 28; 72(3):213-33. PubMed ID: 3418334
    [Abstract] [Full Text] [Related]

  • 10. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B, Grünberger J, Anderer P, Linzmayer L, König P.
    Arzneimittelforschung; 1995 Mar 28; 45(3):217-29. PubMed ID: 7741773
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O, Saletu B, Anderer P, Assandri A, di Padova C, Corrado M, Saletu-Zyhlarz GM.
    Eur Neuropsychopharmacol; 2005 Oct 28; 15(5):533-43. PubMed ID: 16046102
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry.
    Saletu B, Grünberger J, Linzmayer L.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul 28; 24(7):362-73. PubMed ID: 3525428
    [Abstract] [Full Text] [Related]

  • 13. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
    Saletu B, Grünberger J, Linzmayer L, Anderer P.
    Arch Gerontol Geriatr; 1988 Jun 28; 7(2):93-110. PubMed ID: 3415398
    [Abstract] [Full Text] [Related]

  • 14. Clinical pharmacology of vigabatrin.
    Schechter PJ.
    Br J Clin Pharmacol; 1989 Jun 28; 27 Suppl 1(Suppl 1):19S-22S. PubMed ID: 2667604
    [Abstract] [Full Text] [Related]

  • 15. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L.
    Acta Neurol Scand; 1988 Oct 28; 78(4):241-70. PubMed ID: 3146860
    [Abstract] [Full Text] [Related]

  • 16. Effect of vigabatrin on the electroencephalogram in rats.
    Halonen T, Pitkänen A, Koivisto E, Partanen J, Riekkinen PJ.
    Epilepsia; 1992 Oct 28; 33(1):122-7. PubMed ID: 1733745
    [Abstract] [Full Text] [Related]

  • 17. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R, Herranz JL, Valdizán EM, Armijo JA.
    Epilepsia; 1992 Oct 28; 33(5):923-31. PubMed ID: 1396437
    [Abstract] [Full Text] [Related]

  • 18. Stereoselective uptake of the GABA-transaminase inhibitors gamma-vinyl GABA and gamma-acetylenic GABA into neurons and astrocytes.
    Schousboe A, Larsson OM, Seiler N.
    Neurochem Res; 1986 Nov 28; 11(11):1497-505. PubMed ID: 3683730
    [Abstract] [Full Text] [Related]

  • 19. Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.
    Saletu B, Grünberger J.
    Methods Find Exp Clin Pharmacol; 1984 Jun 28; 6(6):317-30. PubMed ID: 6431211
    [Abstract] [Full Text] [Related]

  • 20. Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry.
    Saletu B, Grünberger J, Anderer P, Linzmayer L, Zyhlarz G.
    J Neural Transm (Vienna); 1996 Jun 28; 103(1-2):191-216. PubMed ID: 9026373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.